相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Hans H. Wandall et al.
CANCER RESEARCH (2010)
Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
Hyun-Il Cho et al.
CANCER RESEARCH (2009)
IFN-α Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity
Andrew G. Sikora et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
Vesna Pulko et al.
JOURNAL OF IMMUNOLOGY (2009)
Priming and Activation of Human Ovarian and Breast Cancer-specific CD8+ T Cells by Polyvalent Listeria monocytogenes-based Vaccines
Gomathinayagam Sinnathamby et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes
Tanja Ninkovic et al.
MOLECULAR IMMUNOLOGY (2009)
Advances in specific immunotherapy for prostate cancer
Andrea Kiessling et al.
EUROPEAN UROLOGY (2008)
Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells
Chiara Napoletano et al.
CANCER RESEARCH (2007)
O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes
Tanja Ninkovic et al.
JOURNAL OF IMMUNOLOGY (2007)
PANVAC™-VF:: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma
Ravi A. Madan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat
Mads A. Tarp et al.
GLYCOBIOLOGY (2007)
Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance
AL Sorensen et al.
GLYCOBIOLOGY (2006)
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
Vasso Apostolopoulos et al.
BREAST CANCER RESEARCH (2006)
A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1
KY Tsang et al.
CLINICAL CANCER RESEARCH (2004)
Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility
S Tenzer et al.
JOURNAL OF IMMUNOLOGY (2004)
O-linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells
FG Hanisch et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC
Ö Met et al.
CELLULAR IMMUNOLOGY (2003)
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope
LC Heukamp et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection
MM Soares et al.
JOURNAL OF IMMUNOLOGY (2001)
Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1
GA Pietersz et al.
VACCINE (2000)
分享论文
